Document Detail

Benefits of Prestroke Use of Angiotensin Type 1 Receptor Blockers on Ischemic Stroke Severity.
MedLine Citation:
PMID:  21094055     Owner:  NLM     Status:  Publisher    
BACKGROUND: There is a general agreement that the stroke prevention benefit of antihypertensive agents is mainly based on their blood pressure lowering properties. The aim of this retrospective study was to assess the benefits of angiotensin type 1 receptor blockers (ARBs) used before the onset of ischemic stroke. METHODS: Data were obtained between April 2007 and March 2009 using the discharge statistics of the neurologic service at Juntendo hospital. We retrieved the demographic and clinical characteristics of stroke patients and functional status upon discharge assessed by the modified Rankin Scale (mRS) and Barthel index (BI). RESULTS: We enrolled 151 patients. Patients treated with ARBs were less often treated with a calcium channel blocker (CaB)/angiotensin-converting enzyme inhibitor (ACEI). They often had diabetes and showed better outcomes than the non-ARB group. Logistic regression analysis indicated that in patients with a mRS score of 0 to 2, older age (P < .007) was associated with severe outcomes, while the factor of pretreatment with ARB (P < .014) was associated with better outcomes. For patients with BI scores of more than 75, older age (P < .015) and large artery atherosclerosis (P < .035) were associated with severe outcomes. Logistic regression analysis identified the factor of pretreatment with ARB (P < .020) to be associated with better outcomes. CONCLUSIONS: ARB is widely used in patients with hypertension and cardiovascular disease, and our results further support this indication.
Nobukazu Miyamoto; Yasutaka Tanaka; Yuji Ueno; Ryota Tanaka; Nobutaka Hattori; Takao Urabe
Related Documents :
16777915 - Direct comparison of b-type natriuretic peptide (bnp) and amino-terminal probnp in a la...
10765935 - Increased concentrations of the circulating angiogenesis inhibitor endostatin in patien...
17316335 - Prognostic value of b-type natriuretic peptide in patients with chronic and advanced he...
17544525 - N-terminal pro-b-type natriuretic peptide as a predictor of repeat coronary revasculari...
17267695 - Nephrogenic systemic fibrosis: risk factors and incidence estimation.
8353445 - Intraparenchymal brain stem radiosurgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-11-19
Journal Detail:
Title:  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association     Volume:  -     ISSN:  1532-8511     ISO Abbreviation:  J Stroke Cerebrovasc Dis     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111633     Medline TA:  J Stroke Cerebrovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Department of Neurology, Juntendo University School of Medicine, Tokyo.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fatigue-related decrease in Piper rhythm frequency of the abductor pollicis brevis muscle during iso...
Next Document:  Association between renal function and CYP3A5 genotype in heart transplant recipients treated with c...